Rna Diagnostics Announces $5M Series A Financing Round Led by iGAN Partners rnadiagnostics.com/rna-diagnostic… Canadian Innovation CBC Canadian News

Rna Diagnostics Inc., a #Canadian company with a patented platform #technology providing real-time #cancer therapy guidance, announced today the closing of a $5 million Series A financing rnadiagnostics.com/rna-diagnostic… Minister of Science Ontario Innovation

Rna Diagnostics Inc., a #Canadian company with a patented platform #technology providing real-time #cancer therapy guidance, announced today the closing of a $5 million Series A financing rnadiagnostics.com/rna-diagnostic… @OCEinnovation Ontario Economy Economic Development

Rna Diagnostics Inc., a #Canadian company with a patented platform #technology providing real-time #cancer therapy guidance, announced today the closing of a $5 million Series A financing. rnadiagnostics.com/rna-diagnostic… Ontario Trade Canada Trade

Rna Diagnostics Inc., a #Canadian company with a patented platform #technology providing real-time #cancer therapy guidance, announced today the closing of a $5 million Series A financing. rnadiagnostics.com/rna-diagnostic… Thierry Weissenburger

Innovation for a Greater Sudbury: The Future of MedTech is happening this Thursday evening. Our keynote speaker is @JeremyLaurinOCE, followed by a local roundtable that includes Rna Diagnostics Inc., MetricAid and Verv Technologies. RSVP: igs2018-medtech.eventbrite.ca

Holding a PhD in biochem from York University & medicine fellowships from Harvard University and Temerty Medicine, Dr. Amadeo Parissenti, Chief Scientific Officer of Rna Diagnostics Inc. and Laurentian University - Université Laurentienne professor is an authority on drug resistance in breast & ovarian cancer.

Dr Amadeo Parissenti, Chief Scientific Officer of Rna Diagnostics Inc., believes it is important for Northern Ontario to innovate in the medtech sector to provide more efficient, personalized, and cost efficient healthcare for the aging population. #IGS2018

Innovation for a Greater Sudbury was a rousing success last night. Some great insights from @JeremyLaurinOCE, MetricAid, Rna Diagnostics Inc., Verv Technologies and Madiha Khan, our moderator. Thanks to everyone who joined us. The future of MedTech in northern Ontario is bright

Dr Amadeo Parissenti took part in #IGS2018 round table on the #medtech sector in #NorthernOntario. Discussing his success with Rna Diagnostics Inc. and the Brevity trial.

BREVITY is open and accruing patients! Learn more about how a partnership w/ HSNRI Rna Diagnostics Inc. Laurentian University - Université Laurentienne and HSN Physicians is helping breast cancer patients. bit.ly/2kfFpMr Plus de renseignements ici! bit.ly/2ksrKlj

Whether partnering with @hard_lineglobal to create effective learning environments for students or Rna Diagnostics Inc. to improve patient outcomes, Laurentian University - Université Laurentienne is committed to building a sustainable and innovative economy with its local community Ontario's Universities bit.ly/RegEcDev

After a quick presentation of our tools, Aifred Health and Jeremy Bridge-Cook from Rna Diagnostics Inc. will present the challenges they faced and how MEDTEQ helped them overcoming those challenges. Cc Julien C and Iris LEROUX

President/CEO Jeremy Bridge-Cook explains how RNA Disruption Assay (RDA) test will impact #breastcancer treatment in future. BREVITY is the current international #breastcancer clinical trial for validation of RDA. For more info visit the website in bio youtube.com/watch?v=fCOrI6…

President/CEO Jeremy Bridge-Cook explains how RNA Disruption Assay (RDA) will impact #breastcancer treatment in future. BREVITY is Rna Diagnostics’ current international breast cancer clinical trial for validation of RDA. Startup Canada @startuphereTO youtube.com/watch?v=fCOrI6…

President/CEO Jeremy Bridge-Cook explains how RNA Disruption Assay will impact #breastcancer treatment in future. BREVITY is Rna Diagnostics’ current international #breastcancer clinical trial for validation of RDA. Gisele Roberts Laurentian University - Université Laurentienne HSNRI youtube.com/watch?v=fCOrI6…

President/CEO Jeremy Bridge-Cook explains how RNA Disruption Assay (RDA) will impact #breastcancer treatment in future. BREVITY is Rna Diagnostics’ current international breast cancer clinical trial for validation of RDA. Life Sciences Ontario @OCEinnovation youtube.com/watch?v=fCOrI6…

President/CEO Jeremy Bridge-Cook explains how RNA Disruption Assay (RDA) will impact #breastcancer treatment in future. BREVITY is Rna Diagnostics’ current international breast cancer clinical trial for validation of RDA. NORCAT StartupNorth youtube.com/watch?v=fCOrI6…

President/CEO Jeremy Bridge-Cook explains how RNA Disruption Assay (RDA) will impact #breastcancer treatment in future. BREVITY is Rna Diagnostics’ current international breast cancer clinical trial for validation of RDA. Visit website in bio BreastCancer Chat WW #BCCWW youtube.com/watch?v=fCOrI6…

As we near the 10 year anniversary of the creation of Rna Diagnostics Inc., here's an outstanding description of the technology behind the discovery by Laurentian University - Université Laurentienne prof Amadeo Parissenti that saves lives, improves cancer patient outcomes and lowers treatment costs. #cdninnovation